Search

Author/Creator Mehra, N.

1. 16th IHIW: Analysis of HLA Population Data, with updated results for 1996 to 2012 workshop data (AHPD project report). (22nd December 2012)

Authors:
Riccio, M. E.; Buhler, S.; Nunes, J. M.; Vangenot, C.; Cuénod, M.; Currat, M.; Di, D.; Andreani, M.; Boldyreva, M.; Chambers, G.; Chernova, M.; Chiaroni, J.; Darke, C.; Di Cristofaro, J.; Dubois, V.; Dunn, P.; Edinur, H. A.; Elamin, N.; Eliaou, J.‐F.; Grubic, Z.
Journal:
International journal of immunogenetics
Issue:
Volume 40:Number 1(2013:Feb.)
Page Start:
21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients. (September 2015)

Authors:
Rescigno, P.; Lorente, D.; Bianchini, D.; Kolinsky, M.; Zafeiriou, Z.; Ferraldeschi, R.; Mateo, J.; Recine, F.; Jayaram, A.; Nava Rodrigues, D.; Riisnaes, R.; Miranda, S.; Figueiredo, I.; Crespo, M.; Mehra, N.; Perez-Lopez, R.; Tunariu, N.; Reid, A.; Attard, G.; De Bono, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 2578 Neutrophil-to-lymphocyte ratio (NLR) in relation to outcome of castration-resistant prostate cancer (CRPC) patients treated with corticosteroids (CS). (September 2015)

Authors:
Mehra, N.; Lorente, D.; Jayaram, A.; Bianchini, D.; Zafeiriou, Z.; Kolinsky, M.; Rescigno, P.; Mateo, J.; Thomas, K.; Dearnaley, D.; Parker, C.; De Bono, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). (September 2015)

Authors:
Lorente, D.; Ravi, P.; Mehra, N.; Gillman, A.; Omlin, A.; Pezaro, C.; Miranda, M.; Mateo, J.; Rescigno, P.; Kolinsky, M.; Porta, N.; Jayaram, A.; Bianchini, D.; Hall, E.; Ijzerman, M.J.; De Bono, J.S.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S504
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. (18th October 2016)

Authors:
Massard, C.; Mateo, J.; Loriot, Y.; Pezaro, C.; Albiges, L.; Mehra, N.; Varga, A.; Bianchini, D.; Ryan, C. J.; Petrylak, D. P.; Attard, G.; Shen, L.; Fizazi, K.; de Bono, J.
Journal:
Annals of oncology
Issue:
Volume 28:Number 1(2017)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The HLA‐net GENE[RATE] pipeline for effective HLA data analysis and its application to 145 population samples from Europe and neighbouring areas. Issue 5 (May 2014)

Authors:
Nunes, J. M.; Buhler, S.; Roessli, D.; Sanchez‐Mazas, A.; Andreani, M.; Benhamamouch, S.; Boldyreva, M.; Canossi, A.; Chiaroni, J.; Darke, C.; Di Cristofaro, J.; Dubois, V.; Elamin, N.; Eliaou, J. ‐F.; Fadhlaoui‐Zid, K.; Fischer, G. F.; Grubic, Z.; Jaatinen, T.; Kolesar, L.; Ligeiro, D.
Journal:
Tissue antigens
Issue:
Volume 83:Issue 5(2014)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗